Year: 2018

USC News looks back on the year in construction at USC, highlighting the USC Village and Michelson Hall, home of the USC Michelson Center for Convergent Bioscience, as two projects that “will leave lasting impacts on future generations of Trojans and scientific research.” (December 26, 2017)…Continue Reading ‘An unprecedented year of new buildings’ at USC

USC Viterbi News writes about a new study out of the USC Viterbi School of Engineering that finds tumor growth properties can influence response to cancer drugs. “Identifying a measurement or quantity that predicts how specific tumors will respond, called a predictive biomarker, is extremely valuable to cancer research,” said Stacey Finley, a USC assistant professor of Biomedical Engineering, co-author to the study, the Gordon S. Marshall Early Career Chair, and a faculty member at the USC Michelson Center for Convergent Bioscience. (December 21, 2017)…Continue Reading How a tumor grows can predict response to cancer therapy

USC News writes: “What if scientists could develop an opioid-based painkiller that is not addictive and has limited side effects? That is possible based on new findings by an international team of scientists that included contributions from top researchers at the USC Michelson Center for Convergent Bioscience … The findings were published Jan. 4 in the journal Cell. They are an example of how USC Michelson Center scientists collaborate with a range of experts in multiple disciplines to conduct groundbreaking research.” (January 4, 2018)…Continue Reading Michelson Center researchers advance work on nonaddictive opioid painkiller